Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention.
Fakilahyel S MshelbwalaDaniel W HugenbergRolf P KreutzPublished in: Clinical pharmacology : advances and applications (2020)
Routine use of VN assay in personalized antiplatelet treatment decision-making after PCI is associated with lower likelihood of using novel P2Y12 inhibitors.
Keyphrases
- percutaneous coronary intervention
- decision making
- st segment elevation myocardial infarction
- acute coronary syndrome
- acute myocardial infarction
- coronary artery disease
- st elevation myocardial infarction
- high throughput
- antiplatelet therapy
- clinical practice
- coronary artery bypass grafting
- atrial fibrillation
- left ventricular
- combination therapy
- single cell
- replacement therapy